InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Prepaid Assets of $617211.0 for Q1 2026, up 21.53% year-over-year from $507872.0 in Q1 2025, and down 6.52% quarter-over-quarter from $660280.0 in Q4 2025.
InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Prepaid Assets history runs 7 years deep, the most recent figure standing at $617211.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 21.53% year-over-year to $617211.0; the TTM figure through Mar 2026 stood at $617211.0 (up 21.53% YoY), while the FY2025 annual figure was $319547.0, down 33.11% from the prior year.
- Prepaid Assets for Q1 2026 stood at $617211.0, down from $660280.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.3 million in Q1 2022, with the low at $148882.0 in Q3 2024.
- The 5-year median for Prepaid Assets is $617211.0 (2026), against an average of $611738.6.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 488.51% in 2022, then plunged 50.14% in 2025.
- InMed Pharmaceuticals' Prepaid Assets stood at $826931.0 in 2022, then jumped by 34.59% to $1.1 million in 2023, then plunged by 42.14% to $643986.0 in 2024, then rose by 2.53% to $660280.0 in 2025, then slipped by 6.52% to $617211.0 in 2026.
- Business Quant data shows INM's Prepaid Assets at $617211.0 in Q1 2026, $660280.0 in Q4 2025, and $191755.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 617,211.00 |
| Dec 31, 2025 | 660,280.00 |
| Sep 30, 2025 | 191,755.00 |
| Jun 30, 2025 | 319,547.00 |
| Mar 31, 2025 | 507,872.00 |
| Dec 31, 2024 | 643,986.00 |
| Sep 30, 2024 | 148,882.00 |
| Jun 30, 2024 | 477,749.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 215,015.00 |
| Jun 30, 2023 | 498,033.00 |
| Mar 31, 2023 | 695,203.00 |
| Dec 31, 2022 | 826,931.00 |
| Sep 30, 2022 | 356,665.00 |
| Jun 30, 2022 | 797,225.00 |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 140,512.00 |
| Sep 30, 2021 | 322,352.00 |
| Jun 30, 2021 | 956,762.00 |